A Sleep-Oriented Intervention for Suicidal Behaviors
NCT01770587 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37
Last updated 2020-03-02
Summary
An open-label trial to investigate the use of a behavioral insomnia treatment for suicidal ideation.
Conditions
Interventions
- BEHAVIORAL
-
Behavioral Insomnia Treatment
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
collaborator NIH - lead OTHER
Principal Investigators
-
Rebecca A Bernert, PhD · Stanford University
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-05-31
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- United States
Study Locations
More Related Trials
-
Solriamfetol and CBT-I in Patients With Insomnia Disorder
NCT05838430 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Efficacy and Safety of Subcutaneous Ketamine in the Treatment of Depressive Episode With Suicidal Ideation and/or Behavior in Adolescents
NCT06957704 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Efficacy of Sleeping Without Pills (SWOP), an Online Drug Tapering Program
NCT03194802 ·Status: COMPLETED ·Phase: NA
-
Combined Behavioral/Pharmacological Therapy for Insomnia
NCT00044629 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Bedtime Melatonin in Critically Ill Patients
NCT06156059 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation
NCT04035200 ·Status: COMPLETED ·Phase: PHASE2
-
Management of Insomnia in Breast Cancer Patients
NCT01011218 ·Status: COMPLETED ·Phase: PHASE2
-
Memory Consolidation in Pharmacologically Enhanced Naps
NCT00777829 ·Status: COMPLETED ·Phase: NA
-
Use of Blinded Tapering for Hypnotic Discontinuation
NCT04050176 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients with Severe Insomnia
NCT06053840 ·Status: COMPLETED ·Phase: PHASE4
-
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
NCT00280436 ·Status: COMPLETED ·Phase: PHASE2
-
Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes
NCT03818581 ·Status: COMPLETED ·Phase: PHASE4
-
Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia
NCT00280423 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia
NCT03338764 ·Status: WITHDRAWN ·Phase: PHASE3
-
Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Stage II
NCT06867549 ·Status: RECRUITING ·Phase: PHASE2
-
Sleep Without Insomnia or The Use of Chronic Hypnotics
NCT03687086 ·Status: COMPLETED ·Phase: NA
-
Behavioral and Pharmacological Treatment for Insomnia
NCT00042146 ·Status: COMPLETED ·Phase: PHASE4
-
Appraising Clinical Trial Experiences of Patients With Insomnia
NCT05978271 ·Status: NOT_YET_RECRUITING
-
Radiolabel Study In Healthy Volunteers For Insomnia-Targeting Drug
NCT00520663 ·Status: COMPLETED ·Phase: PHASE1
-
Treating Insomnia and Improving Metabolic Health in Midlife Women With Insomnia
NCT05593653 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional Sleeplessness
NCT00666575 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Participants With Comorbid Major Depressive Disorder (MDD) and Insomnia
NCT03771664 ·Status: TERMINATED ·Phase: PHASE3
-
Characteristics of Sleep Patterns in Young Adults With and Without Insomnia
NCT00177216 ·Status: COMPLETED ·Phase: PHASE4
-
Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder
NCT00552760 ·Status: COMPLETED ·Phase: PHASE4
-
Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers
NCT02491788 ·Status: COMPLETED ·Phase: PHASE4